http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110627871-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae2be58a477cef66248d0dc28cb0ea82
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10
filingDate 2019-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5b1173a824d9bdecbd0c49f87a5067d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5bd07c493c7728fbfc59ec825abeb91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fd29fbbdeb2c33d34fb5c414d8af871
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc4e9ee6cd9e8f1858c5316635603203
publicationDate 2019-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110627871-A
titleOfInvention Cationic bridged staple peptide and its application
abstract The invention discloses a cationic bridged staple peptide. The staple peptide is a cyclic polypeptide with 10 to 20 amino acid residues, and has the following sequence and structural features: the polypeptide sequence can be P n ‑K c ‑ P m ‑K c ‑P i is a general formula; among them, P n , P m , and P i are polypeptide fragments with "n", "m" and "i" amino acid residues, n and i are natural numbers, and m is 3 or 6; where K represents lysine, and c represents the formation of a ring structure between two lysine side chain amino groups. The invention provides the preparation method and application of the cationic bridged staple peptide. The invention innovatively forms a ring structure on the side of the hydrophilic surface of the amphiphilic cationic antibacterial peptide to prepare a class of staple antibacterial peptide. This type of antimicrobial peptide has the following advantages: it has broad-spectrum antibacterial activity, especially has a significant inhibitory effect on clinical drug-resistant bacteria; it has a simple structure and is easy to synthesize; it has good biological stability; it can be applied to the prevention and treatment of human or animal infectious diseases or tumors. treat.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023056715-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112778403-A
priorityDate 2019-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141735
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416060641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453284053
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453705369
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136327
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13402708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419567750
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419567713
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419857615
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID688217
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5367417
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21663959
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414877687
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410098773
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19871184
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66665
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453739895
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15540
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53629311
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415742592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416150763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396425
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426081953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423390804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415742491
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9833444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426149775

Total number of triples: 56.